SRDX - Surmodics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Surmodics, Inc.

9924 West 74th Street
Eden Prairie, MN 55344
United States
952-500-7000
http://www.surmodics.com

SectorHealthcare
IndustryDiagnostics & Research
Full Time Employees338

Key Executives

NameTitlePayExercisedYear Born
Mr. Gary R. MaharajCEO, Pres & Director1.33M2.68M1963
Mr. Timothy J. ArensChief Financial Officer423.63k1.76M1967
Mr. Bryan K. PhillipsSr. VP of Legal, HR & Information Technology, Gen. Counsel and Sec.587.94k366.62k1971
Mr. Thomas A. GreaneyChief Operating Officer of Medical Devices596.9kN/A1966
Mr. Gregg S. SuttonVP of R&D - Medical Devices489.9k794.15k1960
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Surmodics, Inc., together with its subsidiaries, provides medical devices and in vitro diagnostic technologies to the healthcare industry in the United States and internationally. The company operates through two segments, Medical Device and In Vitro Diagnostics. The Medical Device segment designs, develops, and manufactures interventional medical devices primarily for the peripheral vascular market; and offers surface modification coating technologies to enhance access, deliverability, and predictable deployment of medical devices, as well as drug delivery coating technologies to provide site-specific drug delivery from the surface of a medical device for the coronary, peripheral, neuro-vascular, urology, and other markets. The Vitro Diagnostics segment provides stabilization products, substrates, antigens, and surface coatings to diagnostics customers; and manufactures or sells components for in vitro diagnostic immunoassay and molecular tests, as well as surface coatings to the diagnostic, biomedical research, and life science markets. Surmodics, Inc. was founded in 1979 and is headquartered in Eden Prairie, Minnesota.

Corporate Governance

Surmodics, Inc.’s ISS Governance QualityScore as of July 29, 2019 is 4. The pillar scores are Audit: 3; Board: 1; Shareholder Rights: 5; Compensation: 5.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.